Beijing Tiantan Biologic. (600161) Company Profile


	The Wright Reports site is no longer hosted or operated by Manta. Please review the following: 1. You have been redirected to CorporateInformation.com where you can view Snapshot reports or purchase Wright reports or subscriptions of your choosing. 2. If you were previously linking to Wright Reports please change your links to www.corporateinformation.com 3. If you are a paid subscriber with an active subscription please continue on to the member site: http://member.corporateinformation.com/home.asp 4. For additional information related to CorporateInformation.com please contact help@corporateinformation.com, Contact phone nr to be provided later)

Beijing Tiantan Biologic. Company Snapshot

Business Description:

Beijing Tiantan Biologic. operates in the Biological products exc. diagnostic sector. Beijing Tiantan Biological Products Corporation Limited is principally engaged in biopharmaceutical industry. The Company provides biological products, including influenza A (H1N1) vaccine (split, inactivated), preventive products and blood products, such as hepatitis B vaccines, poliomyelitis vaccines, measles-mump-rubella (MMR) vaccines, encephalitis B vaccines, influenza vaccinations, bacterial vaccines, human serum albumin (HSA) and mainline human immunoglobulin (HIg), among others. It distributes its products principally in domestic market. As of December 31, 2010, the Company had seven subsidiaries and two affiliates, which involved in the manufacture and distribution of biological products. In our complete report available for purchase the company is compared to: Hualan Biological Engineering,Inc., China Biologic Products, Inc. and Chongqing Zhifei Biological Products Co Ltd.

Beijing Tiantan Biologic.

Stock Data:

Recent Stock Performance:

Current Price (2/3/2012): 14.86
(Figures in Chinese Renmimbi)

1 Week	n/a	13 Weeks	4.9%

4 Weeks	-17.0%	52 Weeks	-29.2%

Beijing Tiantan Biologic. Key Data:

Ticker:	600161	Country:	CHINA

Exchanges:	SHG	Major Industry:	Drugs, Cosmetics & Health Care

		Sub Industry:	Ethical Drug Manufacturers

2010 Sales	1,202,261,000 (Year Ending Jan 2011).	Employees:	2,536

Currency:	Chinese Renmimbi	Market Cap:	7,659,837,658

Fiscal Yr Ends:	December	Shares Outstanding:	515,466,868

Share Type:	A Gu	Closely Held Shares:	N/A

Feedback | Terms and Conditions | Privacy Policy | Site Index

CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.